Population Pharmacokinetics and Dosing Recommendations for Cisplatin during Intraperitoneal Peroperative Administration

By Ehrsson Hans  

Clinical Pharmacokinetics, Vol. 48, Iss. 10, 2009-10 ,pp. : 685-686

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics and Pharmacodynamics of Mitomycin During Intraoperative Hyperthermic Intraperitoneal Chemotherapy

By Serge van Ruth  

Clinical Pharmacokinetics, Vol. 43, Iss. 2, 2004-01 ,pp. : 131-143

Adis International

Access to resources Recommend Favorite

Organ distribution of cisplatin after intraperitoneal administration of cisplatin-loaded microspheres

By Tamura T.   Imai J.   Matsumoto A.   Tanimoto M.   Suzuki A.   Horikiri Y.   Suzuki T.   Yoshino H.   Ike O.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 54, Iss. 1, 2002-07 ,pp. : 1-7

Elsevier

Access to resources Recommend Favorite

The Role of Population Pharmacokinetics in Drug Development in Light of the Food and Drug Administration's ‘Guidance for Industry: Population Pharmacokinetics’

By Williams P.J.  

Clinical Pharmacokinetics, Vol. 39, Iss. 6, 2000-12 ,pp. : 385-395

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Dosing Recommendations of Tenofovir Disoproxil Fumarate in Hepatic or Renal Impairment

By Kearney Brian P.   Yale Kitty   Shah Jaymin   Zhong Lijie   Flaherty John F.  

Clinical Pharmacokinetics, Vol. 45, Iss. 11, 2006-01 ,pp. : 1115-1124

Adis International

Access to resources Recommend Favorite